KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to 0.06%.

  • Fulgent Genetics' Return on Capital Employed rose 1200.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 1200.0%. This contributed to the annual value of 0.06% for FY2024, which is 900.0% up from last year.
  • Latest data reveals that Fulgent Genetics reported Return on Capital Employed of 0.06% as of Q3 2025, which was up 1200.0% from 0.06% recorded in Q2 2025.
  • Fulgent Genetics' Return on Capital Employed's 5-year high stood at 0.86% during Q1 2021, with a 5-year trough of 0.18% in Q3 2024.
  • Its 5-year average for Return on Capital Employed is 0.17%, with a median of 0.06% in 2023.
  • Per our database at Business Quant, Fulgent Genetics' Return on Capital Employed surged by 8600bps in 2021 and then plummeted by -5300bps in 2023.
  • Fulgent Genetics' Return on Capital Employed (Quarter) stood at 0.59% in 2021, then plummeted by -77bps to 0.14% in 2022, then plummeted by -217bps to 0.16% in 2023, then skyrocketed by 60bps to 0.06% in 2024, then rose by 2bps to 0.06% in 2025.
  • Its last three reported values are 0.06% in Q3 2025, 0.06% for Q2 2025, and 0.06% during Q1 2025.